References
- Frigas E, Gleich G J. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986; 77: 527
- Gleich G J, Adolphson C R. The eosinophilic leukocyte: Structure and function. Adv Immunol 1986; 39: 177
- Frigas E, Motojima S, Gleich G J. The eosinophil injury to the mucosa of the airways in the pathogenesis of bronchial asthma. Eur Respir J 1991; 4(Suppl 13)123s
- Kay A B. Modulation of eosinophil function in vitro. Clin Exp Allergy 1990; 20(Suppl 4)31
- Spry C JF. Eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature. Oxford Medical Publications, Oxford 1988
- Bradley B L, Azzawi M, Jacobson M, Assoufi B, Collins J V, Irani A-MA, Schwartz L B, Durham S R, Jeffery P K, Kay A B. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661
- Walker C, Kaegi M K, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935
- Rubin L A, Nelson D L. The soluble interleukin-2 receptor: Biology, function, and clinical application. Ann Intern Med 1990; 113: 619
- Tokano Y. The clinical significance of the quantitation of serum soluble interleukin-2 receptors. Clin Immunol Jpn 1989; 21: 1470
- Leonard W J, Deppler J M, Robb R J, Waldman T A, Greene W C. Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci USA 1983; 80: 6957
- Saiki O, Tanaka T, Doi S, Kishimoto S. Expression and functional role of a p70/75 interleukin-2 binding molecule in human B cell. J Immunol 1988; 140: 853
- Kehrl J H, Dukovich M, Whalen G, Katz P, Fauci A S, Greene W. Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J Clin Invest 1988; 81: 200
- Rubin L A, Kurman C C, Fritz M E, Biddison W E, Boutin B, Yarchoan R, Nelson D L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172
- Holter W, Goldman C K, Casabo L, Nelson D L, Greene W C, Waldmann T A. Expression of functional IL 2 receptors by lipopolysaccharide and interferon-γ stimulated human monocytes. J Immunol 1987; 138: 2917
- Rand T H, Silberstein D S, Kornfeld H, Weller P F. Human eosinophils express functional interleukin 2 receptors. J Clin Invest 1991; 88: 825
- Nelson D L, Rubin L A, Kurman C C, Fritz M E, Boutin B. An analysis of the cellular requirements for the production of soluble interleukin-2 receptor in vitro. J Clin Immunol 1986; 6: 114
- Kawai M. Symptoms and clinical course of adult bronchial asthma patients. Igaku-no Ayumi 1991; 159: 668
- Motojima S, Hirata A, Fukuda T, Makino S. High serum soluble interleukin-2 receptor concentrations in elderly individuals and smokers. Jpn J Allergol 1993; 42: 1175
- Brown P H, Crompton G K, Greening A P. Proin-flammatory cytokines in acute asthma. Lancet 1991; 338: 590
- Lassalle P, Sergant M, Delneste Y, Gosset P, Wallaert B, Zandecki M, Capron A, Joseph M, Tonnel A B. Levels of soluble IL-2 receptor in plasma from asthmatics: Correlations with blood eosinophilia, lung function, and corticosteroid therapy. Clin Exp Immunol 1992; 87: 266
- Corrigan C J, Kay A B. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis 1990; 141: 970
- Orson F M, Saadeh C K, Lewis D F, Nelson D L. Interleukin 2 receptor expression by T cells in human aging. Cell Immunol 1989; 124: 287
- Ginns L C, De Hoyos A, Brown M C, Gaumond B R. Elevated concentration of soluble interleukin-2 receptors in serum of smokers and patients with lung cancer: Correlation with clinical activity. Am Rev Respir Dis 1990; 142: 398
- Barker R L, Loegering D A, Ten R M, Hamman K J, Pease L R, Gleich G J. Eosinophil cationic protein cDNA: Comparison with other toxic cationic proteins and ribonucleases. J Immunol 1989; 143: 952
- Corrigan J C, Haczku A, Gemou-Engesaeth V, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5: Effect of glucocorticoid therapy. Am Rev Respir Dis 1993; 147: 540